Literature DB >> 9094025

Portosystemic shunting for paediatric portal hypertension.

A Shun1, D P Delaney, H C Martin, G M Henry, M Stephen.   

Abstract

The records of 22 patients who received portosystemic shunting for portal hypertension from 1985 to 1995 inclusive at the Royal Alexandra Hospital for Children (RAHC) were retrospectively reviewed. There were 11 girls and 11 boys. The average age at operation was 8 years, 3 months (range, 2 years, 3 months to 16 years, 7 months). The aetiology was idiopathic portal cavernomatous transformation (n = 9), billiary atresia (n = 4), cystic fibrosis (n = 3), documented neonatal portal vein thrombosis (n = 3), congenital hepatic fibrosis (n = 2), and portal vein obstruction after liver transplant (n = 1). The major presenting problem was upper gastrointestinal haemorrhage. Two patients had recurrent melaena from Roux-en-Y jejunal loop and caecal varices, respectively. Before receiving shunts, 12 patients had endoscopic sclerotherapy, 1 had gastric transection, and 2 had gastric varices oversewn. Portal pressure at preoperative splenoportogram averaged 28 mm Hg (range, 20 to 41). Urgent shunts were performed on 13 patients. Two disadvantaged patients had prophylactic shunts for severe hypersplenism. The types of shunts used were reversed splenorenal (n = 13), splenoadrenal (n = 6), inferior mesenteric renal (n = 1), portocaval (n = 1), inferior mesenteric caval (n = 1), and superior and inferior mesenteric caval (n = 1). In all, 22 patients had 23 shunts. The patency rate was 96% on 6 months to 10 years follow-up (average, 5.8 years). No spleen was lost. There were 2 late deaths. Two cystic fibrosis patients and one child with extrahepatic portal hypertension experienced post-shunt encephalopathy. Three patients rebled in the early postoperative period despite a patent shunt. Two patients subsequently received liver transplantation without any additional difficulties. Thus, portosystemic shunting using a method appropriate for the patient is a reliable option for treating children with portal hypertension in whom variceal sclerotherapy is inappropriate or has failed.

Entities:  

Mesh:

Year:  1997        PMID: 9094025     DOI: 10.1016/s0022-3468(97)90613-8

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Hepatic Cysts.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  End-stage Liver Disease in Children.

Authors:  Robert H. Squires
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

3.  Liver transplantation for cirrhosis in cystic fibrosis.

Authors:  T Lamireau; S Martin; M Lallier; J E Marcotte; F Alvarez
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

4.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

5.  Portosystemic shunt for portal hypertension after Kasai operation in patients with biliary atresia.

Authors:  Toru Shimizu; Albert Shun; Gordon Thomas
Journal:  Pediatr Surg Int       Date:  2020-11-17       Impact factor: 1.827

6.  Creation of a percutaneous mesocaval shunt to control variceal bleeding in a child.

Authors:  Colin Burke; Andrew G Taylor; Ernest J Ring; Robert K Kerlan
Journal:  Pediatr Radiol       Date:  2013-02-28

7.  Extrahepatic portal hypertension in children: observations on three surgical procedures.

Authors:  K L N Rao; Anju Goyal; Prema Menon; B R Thapa; K L Narasimhan; S K Chowdhary; R Samujh; J K Mahajan
Journal:  Pediatr Surg Int       Date:  2004-09-04       Impact factor: 1.827

8.  Effects of splenohepatopexy and omentopexy in experimentally induced infrahepatic portal hypertension in rats.

Authors:  Dilek Polat; Riza Rizalar; Burak Tander; Levent Yildiz; Ender Aritürk; Ferit Bernay
Journal:  Pediatr Surg Int       Date:  2004-04-20       Impact factor: 1.827

Review 9.  Clinical characteristics of Caroli's syndrome.

Authors:  Ozlem Yonem; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

10.  Correction of extrahepatic portal vein thrombosis by the mesenteric to left portal vein bypass.

Authors:  Riccardo Superina; Daniel A Bambini; Joan Lokar; Cynthia Rigsby; Peter F Whitington
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.